What is Factor VII Deficiency

Factor VII deficiency is a rare inherited bleeding disorder caused by a lack of the protein factor VII, which is essential for the blood to clot correctly. Symptoms vary significantly from person to person, ranging from mild bruising and nosebleeds to severe, life-threatening internal bleeding.

What causes Factor VII deficiency?

Factor VII deficiency is primarily a genetic condition caused by mutations in the F7 gene. This gene provides instructions for producing the factor VII protein, a critical component of the coagulation cascade. When levels are low or the protein does not function, the body cannot form a stable "plug" at the site of an injury, leading to prolonged bleeding. In the DiseaseMaps community, we have seen 40 individuals share their experiences, highlighting the wide spectrum of severity found in this condition.

How common is Factor VII deficiency and who is affected?

The prevalence of Factor VII deficiency is estimated at approximately 1 in 300,000 to 500,000 people in the general population. It affects males and females equally, as the condition is inherited in an autosomal recessive pattern. This means an individual must inherit two copies of the mutated gene—one from each parent—to manifest symptoms. While it is found worldwide, it may be more frequently identified in populations where consanguineous marriages (marriages between close relatives) are more common.

What are the primary clinical features of Factor VII deficiency?

Unlike hemophilia A or B, which often present with joint bleeds, the symptoms of Factor VII deficiency are highly variable and do not always correlate with laboratory test results. Common manifestations include:

• Frequent or severe nosebleeds (epistaxis)


• Easy bruising


• Heavy or prolonged menstrual bleeding (menorrhagia)


• Bleeding after surgery, dental extractions, or trauma


• Rare cases of intracranial hemorrhage or gastrointestinal bleeding

How is Factor VII deficiency different from other bleeding disorders?

A key clinical hallmark of Factor VII deficiency is that many individuals with low laboratory levels of the protein remain asymptomatic throughout their lives. Furthermore, the "Prothrombin Time" (PT) is typically prolonged, while the "Activated Partial Thromboplastin Time" (aPTT) remains normal, which helps clinicians differentiate Factor VII deficiency from other common coagulation factor deficiencies.

Next steps

• Consult a hematologist who specializes in rare bleeding disorders for a formal diagnosis and management plan.


• Request genetic counseling to understand the inheritance pattern and risks for other family members.


• Join the DiseaseMaps.org community to connect with other patients and share experiences.


• Keep a detailed "bleeding diary" to help your medical team track your symptoms and treatment efficacy.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the guidance of your physician regarding a medical condition.

References

• National Institutes of Health (NIH) - Genetic and Rare Diseases Information Center (GARD)


• Orphanet: Portal for rare diseases and orphan drugs


• Online Mendelian Inheritance in Man (OMIM) - Entry #227500


• World Federation of Hemophilia (WFH) guidelines on rare bleeding disorders